Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Dawa Pharmaceutical Invest Sweden AB
AB
Active
Org 5568460041
C/O Kungspoprtsavenyn 4, 411 36
Göteborg
Other financial service activities, except insurance and pension funding n.e.c.
· NACE 6499
Est. 2011
0 employees
Watchlist
Share
Sweden
/
Companies
/
Other financial service activities, except insurance and pension funding n.e.c.
/
Dawa Pharmaceutical Invest Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
-8M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−32
−32
−24
318
−7 685
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−32
−32
−24
318
−7 685
Net financials
232
51
−118
−274
7 790
Profit before tax
293
50
31
−43
106
Tax
−0
−0
−0
−14
−0
Net profit
293
50
31
−57
106
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 671
1 719
689
14 569
51 193
Equity
430
480
111
54
160
Long-term debt
1 211
1 209
542
821
17 989
Short-term debt
30
30
35
13 694
33 044
Total debt
1 241
1 239
577
14 515
51 033
Financial ratios
5-year trend
EBITDA margin
-768500000.0%
This company
15.8%
Market median
-4863924151% vs market
2020
2024
Equity ratio
0.3%
This company
38.2%
Market median
-99% vs market
2020
2024
Return on equity
66.3%
This company
18.4%
Market median
+260% vs market
2020
2024
Net profit margin
10600000.0%
This company
8.1%
Market median
+130864098% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
318.96×
This company
0.62×
Market median
-51345% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Dawa Pharmaceutical Invest Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
